Aviance Capital Management LLC raised its holdings in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 34,819.6% in the second quarter, Holdings Channel reports. The institutional investor owned 17,809 shares of the financial services provider’s stock after buying an additional 17,758 shares during the quarter. Aviance Capital Management LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $1,956,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also modified their holdings of the company. Quadrant Capital Group LLC bought a new stake in shares of iShares Nasdaq Biotechnology ETF during the first quarter valued at approximately $111,000. Bedel Financial Consulting Inc. bought a new stake in shares of iShares Nasdaq Biotechnology ETF during the first quarter valued at approximately $119,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors bought a new stake in shares of iShares Nasdaq Biotechnology ETF during the second quarter valued at approximately $134,000. KHP Capital LLC increased its position in shares of iShares Nasdaq Biotechnology ETF by 61.1% during the second quarter. KHP Capital LLC now owns 1,450 shares of the financial services provider’s stock valued at $159,000 after purchasing an additional 550 shares during the period. Finally, Personal Resources Investment & Strategic Management Inc. bought a new stake in shares of iShares Nasdaq Biotechnology ETF during the second quarter valued at approximately $205,000. Institutional investors own 64.86% of the company’s stock.

IBB opened at $122.03 on Friday. iShares Nasdaq Biotechnology ETF has a 1 year low of $100.22 and a 1 year high of $122.49.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading: Market Capitalization and Individual Investors

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.